These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4924709)

  • 21. [Clinical studies on the effectiveness of Xantinol-nicotinate in chronic hepatitis and liver cirrhosis].
    Dohrmann RE; Konrad D; Sawade H; Kühl I
    Med Klin; 1968 Nov; 63(44):1772-6. PubMed ID: 5704508
    [No Abstract]   [Full Text] [Related]  

  • 22. [6-Mercaptopurine in the treatment of diffuse inflammatory liver diseases].
    Solís Herruzo JA; De Portugal Alvarez J
    Rev Clin Esp; 1967 Dec; 107(5):329-42. PubMed ID: 5618869
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of patients with chronic hepatitis and cirrhosis of the liver].
    Kurdybaĭlo FV; Larina IG; Kulikova AN
    Vrach Delo; 1972 Jun; 6():19-23. PubMed ID: 5043595
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic effects of 6-mercaptopurine on liver diseases].
    Kosaka K; Ota Y; Takemura H
    Nihon Rinsho; 1966 Jun; 24(6):1174-84. PubMed ID: 6007379
    [No Abstract]   [Full Text] [Related]  

  • 25. [The treatment of inflammatory liver diseases with 6-mercaptopurine (6-MP)].
    Weinreich J
    Acta Hepatosplenol; 1967; 14(4):189-98. PubMed ID: 5589685
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical study of citiolone, cyto-membranous hepatic protector].
    Varay A; Castel A; Bloch J
    Therapeutique; 1970 Dec; 46(10):993-5. PubMed ID: 5511936
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of chronic hepatitis and liver cirrhosis with the oral antidiabetic tolbutamide (Orabet)].
    Schimmelpfennig W; Wagner K; Schneider G; Theuer D; Schimmelpfennig R; Zimmermann HB; Hecht A
    Dtsch Gesundheitsw; 1969 Oct; 24(44):2074-9. PubMed ID: 5385540
    [No Abstract]   [Full Text] [Related]  

  • 28. [Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
    Tamarkina AD; Neverov IV; Turitsyna IG; Dement'eva ES; Krylova NI
    Sov Med; 1985; (12):26-30. PubMed ID: 4095626
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of chronic diseases of the liver parenchyma with thioctic acid].
    Dabski H; Brzeski Z
    Pol Tyg Lek; 1970 Jun; 25(24):899-901. PubMed ID: 4913117
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of furosemide on the liver function].
    Pickert H; Müller K; Henning H
    Ther Ggw; 1966 Feb; 105(2):250-4. PubMed ID: 5915868
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of repeat courses of unithiol in the complex treatment of liver cirrhosis].
    Khvorostinka VN; Teslenko VG; Khvisiuk SS; Kosenko NP; Borisenko GV
    Vrach Delo; 1986 Mar; (3):75-9. PubMed ID: 3087063
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evolution of chronic diffuse liver diseases treated by essential choline phospholipid therapy. Clinical and analytical control through exploration with radioactive isotopes].
    Galán Navarro JL
    Rev Esp Enferm Apar Dig; 1967 Apr; 26(4):460-90. PubMed ID: 5603013
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of prednisolone on the blood coagulation system in chronic hepatitis].
    Krutovskaia OV
    Klin Med (Mosk); 1967 Aug; 45(8):70-3. PubMed ID: 5610475
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experience in the use of the Soviet drug riboxin in therapeutic practice].
    Komarov FI; Ol'binskaia LI; Vartanova OA; Ovchinnikova LV; Pogromov AP
    Sov Med; 1979 Dec; (12):82-3. PubMed ID: 531611
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thiomesterone and liver function].
    Pickert H
    Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract]   [Full Text] [Related]  

  • 36. [Contribution on the therapy of chronic liver parenchymal damage with 6-mercaptopurine].
    Mott R; Knief J; Faul J
    Med Klin; 1968 Sep; 63(36):1422-8. PubMed ID: 5729432
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinico-morphological dynamics of chronic diffuse liver diseases].
    Loginov AS; Blok IuE; Shepeleva SD; Tkachev VD
    Ter Arkh; 1981; 53(11):50-9. PubMed ID: 7339906
    [No Abstract]   [Full Text] [Related]  

  • 38. [Long term therapy of chronic progressive (aggressive) hepatitis using a combination of imuran and prednisone].
    Schimmelpfennig W; Wagner K; Theuer D; Schneider G; Hecht A; Schimmelpfennig R
    Dtsch Gesundheitsw; 1971 Oct; 26(42):1965-71. PubMed ID: 5004132
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the therapy of chronic inflammatory liver diseases without or with vitamin B 12-folic acid].
    Burgmann W
    Munch Med Wochenschr; 1966 Sep; 108(37):1805-8. PubMed ID: 6014771
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experimentation with Aïcamine in hepatic insufficiency].
    Négret JP
    Bord Med; 1972 Apr; 5(8):973-6. PubMed ID: 5053280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.